dogs

clinical trials

trial name conditions enrollment ends
A dose-finding study of cannabidiol in dogs with idiopathic epilepsy epilepsy December 31, 2024 Adjuvant immunotherapy combination with losartan/toceranib/ladarixin for non-metastatic osteosarcoma osteosarcoma Asparaginase, procarbazine, prednisone, and lomustine for canine multicentric lymphoma lymphoma Biomarker research in aging dogs (BioRAD): A brain aging study in dogs healthy December 31, 2030 Brain tumor biobanking brain tumor December 31, 2030 Canine Brain Tumor Vaccine Clinical Trial glioma Canine traumatic injury stabilization (BodeVet/LoVLETR) penetrating trauma CAR T cell immunotherapy for treatment of metastatic osteosarcoma in dogs osteosarcoma Clinical characteristics and long-term outcome in dogs diagnosed with a ductal plate malformation ductal plate malformation May 1, 2034 Combination therapy with gilvetmab and toceranib in dogs with mast cell tumors mast cell tumor Combination trametinib and sapanisertib for canine malignant neoplasia neoplasia COTC027: Preclinical Comparison of Two Hypomethylating Nucleosides in Tumor-Bearing Dogs solid tumor COTC031: Novel immune therapy for dogs with lymphoma or solid tumors solid tumor COTC033: Repurposing vaccine immunity to treat cancers, validation in canine patients neoplasia Evaluation of adaptation time in dogs undergoing limb amputation for osteosarcoma osteosarcoma Evaluation of thromboprophylaxis medications in dogs with protein-losing enteropathy protein-losing enteropathy May 1, 2024 Focal adhesion kinase inhibition to improve losartan-toceranib immunotherapy in canine metastatic osteosarcoma osteosarcoma Lattice radiation therapy’s effect on the immune response in canine sinonasal carcinoma sinonasal carcinoma Local immune response to radiation therapy and combined myeloid cell targeted therapy in a dog model of sinonasal carcinoma sinonasal carcinoma Oral melanoma study in dogs oral melanoma Palliative radiation therapy with or without bisphosphonates or carboplatin for dogs with osteosarcoma osteosarcoma Phase I clinical trial of NIH 972 in dogs with spontaneously occurring sarcomas sarcoma Phase-1 evaluation of vismodegib plus carboplatin in dogs with spontaneous osteosarcoma osteosarcoma Single-dose plasma pharmacokinetic analysis of targeted anticancer agents in tumor-bearing dogs malignant neoplasia The effect of intravenous carboplatin on pain control in dogs with appendicular osteosarcoma osteosarcoma TRAC study: Investigating the effect of trazodone, rapamycin, and cannabidiol on cognitive dysfunction in dogs cognitive dysfunction December 31, 2030